John Kenneth Amory

Insider Reports History

Entity
Individual
Location
C/O Clarus Therapeutics Holdings, Inc., 555 Skokie Blvd, Suite 340, Northbrook, IL
Signature
/s/ Steven A. Bourne, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Kenneth Amory:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Clarus Therapeutics Holdings, Inc. Director Common Stock 5.77K Jun 7, 2022 Direct
Clarus Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 4.81K Jun 7, 2022 Direct

Insider Reports Filed by John Kenneth Amory

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRXT Clarus Therapeutics Holdings, Inc. Jun 7, 2022 2 $0 4 Jun 9, 2022 Director
CRXT Clarus Therapeutics Holdings, Inc. Dec 12, 2021 2 $0 4 Dec 14, 2021 Director
CRXT Clarus Therapeutics Holdings, Inc. Sep 9, 2021 0 $0 3 Sep 13, 2021 Director